CT Company Says It May Have Answer to Ineffective Flu Vaccine

Meriden, Conn. (WTNH) – A Meriden-based company says it may have the solution to ineffective flu vaccines.

Protein Sciences manufactures Flublok. The company’s President and CEO Dr. Manon Cox says “a drift in influenza virus strain can effectively be addressed by a strong antibody response. Flublok contains 3X more antigen than traditional trivalent flu vaccines.” The flu usually peaks in February and Flublok is still available.

Recently the Centers for Disease Control and Prevention warned that flu vaccines may be ineffective this year because a new strain of H3N2 influenza virus that is not included in this years’s vaccines is out there.

Cox says his company could begin making an H3N2 vaccine immediately if the Government felt it was necessary and it would be ready in a few months.

WTNH NEWS8 provides commenting to allow for constructive discussion on the stories we cover. In order to comment here, you acknowledge you have read and agreed to our Terms of Service. Commenters who violate these terms, including use of vulgar language or racial slurs, will be banned. Please be respectful of the opinions of others. If you see an inappropriate comment, please flag it for our moderators to review. Also, you can now block any inappropriate user by simple selecting the drop down menu on the right of any comment and selection "Block User" from there.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s